Trial Profile
Continuous Neuromuscular Blocking Agent for out-of Hospital Cardiac Arrest; Multicenter Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Heart arrest
- Focus Therapeutic Use
- 05 Dec 2016 Status changed from recruiting to completed.
- 14 Jun 2016 New trial record